Khamzat Asabaev

Always a great perspective from Thomas Hagemeijer on the latest trends in healthcare. This one is focused on the role consumer and retail are entering and contributing to the healthcare market in the US. This a trend implemented across the globe in various ways, with interesting case studies emerging from the GCC region. Healthcare marketplaces are growing as well as the location of receiving care, especially primary care, is evolving closer to home.

8

Next week we will 🚀 launch Mohtadi BEN FRAJ and his #medtech #startup #team to get serious with #tecdoc and Medical Device #registration for Caire. 𝗖𝗮𝗶𝗿𝗲 𝘂𝘀𝗲𝘀 𝗰𝗼𝗻𝘁𝗮𝗰𝘁𝗹𝗲𝘀𝘀 𝗵𝗲𝗮𝗹𝘁𝗵 𝘀𝗶𝗴𝗻𝗮𝗹 𝗔𝗜 𝗲𝘅𝘁𝗿𝗮𝗰𝘁𝗶𝗼𝗻 𝗳𝗿𝗼𝗺 𝘃𝗶𝗱𝗲𝗼. 𝗧𝗿𝗲𝗺𝗲𝗻𝗱𝗼𝘂𝘀 𝗲𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗮𝗻𝗱 𝗽𝗿𝗼𝗺𝗶𝘀𝗶𝗻𝗴 𝗦𝘁𝗮𝗿𝘁𝘂𝗽. During the roll-on #workshop with Easy13485 QM Service we will guide Caire through tailoring of instruction and templates to exacly fit the #Startup needs. Remember: "Free until DOC"(*) 𝗪𝗵𝗮𝘁 𝗶𝘀𝘁 𝘆𝗼𝘂𝗿 𝗖𝗵𝗼𝗶𝗰𝗲? ❔ Language of #templates and #instructions ✅ EN ⛔ DE ❔ Risk Class of #Medicaldevice ✅ Class I ✨ Class IIa ⛔ Class IIb /III ❔ #MDR Type of Actor ✅Development of MD ✨ Manufacturer ⛔ Dealer ⛔ Importer ❔ Need of Certified QMS ISO 13485? ✨ Needed for Class IIa in Future ❓ Mechanics according to ISO60601-1 ⛔ never ❓ CAPA Processes ⛔ not now✨Needed with Product launch ❓ Post Market Processes ⛔ not now ✨Needed with Product launch ❓ Manufacturing Processes ⛔ never ❓ Manufacturing Validation Processes ⛔ never ❔Tecdoc arroding Annex II ✅ ❔SW Development according to IEC 82304-1 ✅ ❔SW Development according to IEC 62304 ✅ ❔Risk Managment according to ISO 14971 ✅ ❔Usability according to ISO 62366 ✅ ❔IT Security according to IEC 81001-5-1✅ (*) No available Roll on slot in Q2.

27

4 Comments

🚀 Biggest Startup Funding Rounds Last Week🚀 #1: Metsera 💼 Sector: Biotech 💰 Funding: $290M 📝 Details: New York-based Metsera emerged from stealth mode with a whopping $290 million funding round led by Arch Venture Partners. Specializing in medicines for obesity and metabolic diseases, Metsera offers a range of oral and injectable therapies. #2: Rivos Inc. 💼 Sector: Semiconductor 💰 Funding: $250M 📝 Details: Santa Clara's Rivos secured over $250 million in a Series A-3 funding round, spearheaded by Matrix Capital Management. Their expertise lies in power-optimized chips tailored for data analytics and generative AI markets. #3: Ramp 💼 Sector: Fintech 💰 Funding: $150M 📝 Details: New York-based Ramp raised $150 million in their latest funding round led by Khosla Ventures and Founders Fund. With a valuation spike to $7.65 billion, Ramp focuses on streamlining corporate card and expense automation solutions. #4: Two Chairs 💼 Sector: Healthcare 💰 Funding: $72M 📝 Details: San Francisco's Two Chairs closed a $72 million Series C round, enhancing their behavioral health platform. Utilizing a proprietary algorithm, they match patients with suitable therapists, boasting a team of over 500 clinicians. #5: Cape 💼 Sector: Mobile 💰 Funding: $61M 📝 Details: Arlington-based Cape raised $61 million in their debut round led by A* and Andreessen Horowitz. Their focus on developing a privacy-first mobile network addresses prevalent security concerns in the telecom industry. #6: Avive Solutions Inc. 💼 Sector: Healthcare 💰 Funding: $57M 📝 Details: SF's Avive Solutions secured $56.5 million in growth equity financing led by Catalyst Health Ventures, Laerdal Million Lives Fund, and Questa Capital Management. They specialize in connected automated external defibrillators. #7: Asher Biotherapeutics 💼 Sector: Biotech 💰 Funding: $55M 📝 Details: South San Francisco's Asher Biotherapeutics closed a $55 million Series C round led by RA Capital Management. Their focus on targeted immunotherapies for various diseases shows promising potential. #8: Corner Therapeutics 💼 Sector: Biotech 💰 Funding: $54M 📝 Details: Watertown's Corner Therapeutics raised $54 million in funding led by Ziff Capital Partners. Specializing in immunotherapy, they're dedicated to developing innovative treatments. #9: Kontakt.io 💼 Sector: Artificial Intelligence 💰 Funding: $48M 📝 Details: New York-based Kontakt raised $47.5 million in funding led by Goldman Sachs Asset Management. They provide health systems with analytics on staff and patient movement within facilities. #10: Anvilogic 💼 Sector: Cybersecurity 💰 Funding: $45M 📝 Details: Palo Alto's Anvilogic closed a $45 million Series C round led by Evolution Equity Partners. Focusing on security information and event management, they strive to protect organizations from cyber threats. #startups #funding #startupfunding ---- Subscribe to my newsletter: newsletter.foundersbay.com

49

8 Comments

Good Morning everyone ☀️⚡️ The team and I receive lots of inquiries regarding the #3RDACT program and I am happy to share few clarifications so that promising Startups can #Apply: 1️⃣ #3RDACT is the #PreAcceleration program powered by ➡️SB3S #SeedToScaleStudio 2️⃣ It is fully supported by ➡️TAMWILCOM with the #Partnership of INSKIP Entrepreneurs 3️⃣What we #offer 🎫 ✔️Access to a #Honoloan up to #750Kmad (to be reimbursed within 1 year) ✔️Access to a Sharp #Talentpool covering all the functions (#VentureStudio) ✔️Strong push and access to #firstSeedround for up to #4MMad (Witamax #funds) 4️⃣Who can Apply? #PreAcceleration startups with: ✅Strong #MVP ✅Clear #financingPlan #debtorEquity ✅#Topnotch leadership aiming to scale (#Fast!) 5️⃣ Where to Apply and when ? 📍 https://lnkd.in/eAWcT6KA 🔚 #May23rd ! #20startups will be #preselected ⤵️ #10Startups to #embark in this #Chapter🙌

24

2 Comments

🚀 Meet Our Advisors! We are excited to highlight that Bill Reichert, General Partner of Pegasus Tech Ventures, as one of the esteemed advisors in our #H7 accelerator program. 👉 Don't miss out on the opportunity to be part of H7 BioCapital's global healthcare accelerator. Apply now for the #H7 Accelerator Program Online. Early Bird Applications are open until 💥 July 20th 💥! 🦄 Apply for the Program: https://shorturl.at/TfJdB 🦄 Apply to Become Advisor: https://lnkd.in/eSbGpX28  📅 Early Bird Deadline: July 20th, 2024 🎯 About H7 Accelerator Program: https://lnkd.in/g3ycA8eE ------- 🎯Get to know our top-tier accelerator advisor - Bill Reichert! "Bill Reichert is a #veteran #entrepreneur, having been a founder at five startups, two of which went public, and he is a seasoned venture capital investor, with over 200 investments, several in unicorns, and several in #healthtech #startups." 🌷Apply now to learn invaluable insights from Bill Reichert and get connected with our 100+ industrial leading experts, pitch to top #investors, and scale your #startup! 🥳 Once you're selected for #H7 accelerator cohort, you'll be part of the #H7 community for life. Expand your business and expand your network with access to a talented group of founders, investors, mentors, and industry leaders. #accelerator #venturecapital #fundraising #healthcare #lifesciences #biotech #drugdevelopment #artificialintelligence #medicaldevices #entrepreneur #clinicaltrials #oncology #research #startup #founders

23

1 Comment

As an early stage healthcare investor, investing in promising healthcare companies is just one piece of the puzzle; taking a stance on what we believe are important problems to solve in healthcare, and letting people know where we (and other investors!) should to put their capital to work is just as important. Building in healthcare isn't reserved for founders; investors have an active role to play as well. We've been quietly at work at The Healthcare Syndicate building out different ways to engage the founder/investor community beyond our syndicate. If you haven't yet, please sign up to our newsletter to get our latest thoughts on early stage healthcare investing, and important problems in healthcare we believe deserve some highlights. See you there! Subscribe here: https://lnkd.in/g3GFV9Ev #healthcareinnovation #angelinvesting

9

2 Comments

🚀 Breaking News: We're Investing in the Future of Healthcare with Curexel Technologies! 🚀 Am happy to announce our first "zero-to-one" stage investment in Curexel Technologies (https://curexel.com/), a groundbreaking company at the forefront of healthcare innovation. Some of the firsts in this deal, as an early stage investor are: · First investment in #Healthcare devices · Worked zero-to-one stage with founders · Working with the founders on product feasibility, manufacturing partners, distribution partners and overall GTM of the product · Partnered with Asutosh Upadhyay as a co-investor for this deal who brings a wealth of experience in early stage investing and global partner network · Engaged with legal adviser Disha Toshniwal for setting up the company legal framework, cap table etc for us to come onboard with the #firstcheque What is Curexel solving? Curexel's vision is to accelerate medical device based research and build patents towards development of novel drug delivery products and engage with industry to enable distribution and commercialization. The first product is to build an "Intradermal Painless Injection" device which will solve for unreliable delivery, pain induced due to tangential insertion and high degree of skill required by the nurse, using current injection devices. Top 3 key use cases for intradermal injection devices are:  1.    Vaccinations: Intradermal injections are used for certain vaccines, including the Bacillus Calmette-Guérin (BCG) vaccine for tuberculosis and certain influenza vaccines. 2.    Allergy Testing: Intradermal testing is common for detecting allergies in children. This method allows for precise administration of allergens to observe reactions safely. 3.    Local Anesthesia: Intradermal injections are often used to administer local anesthetics before minor procedures or intravenous insertions. Market Opportunity: The global intradermal injection market size was valued at US$3.8 Billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 10.8% from 2022 to 2032 We look forward to supporting Curexel founders Kedar Badnikarvasudha nShreyas N J in their mission to bring innovative and painless drug delivery products for consumers worldwide. If you are keen to partner with Curexel in this journey or if you are keen to invest in their upcoming pre-seed round, please DM. Stay tuned for more updates on this exciting journey! #medicaldevices #healthcare #medicine #enterpreneurship #innovation #startups #venturecapital #investing #technology

89

8 Comments

We’re officially live with VentureBlick Discovery! 🙌🏼   After months of preparation (and talking about it in concept and on paper), I’m pleased to announce that our Discovery platform – where all key players in the healthcare innovation ecosystem can connect and collaborate – is officially launched!   This journey has not been without its fair share of challenges, and we are still at the very early stages of this platform development, but I can already see the immense possibilities of everyone being able to find each other.   Discovery is designed to bring together advisors, investors, innovators, and distributors from all over the world for better visibility, connections, and collaboration. 💡🩺🌍   It will become more meaningful as more and more people from within the healthcare innovation ecosystem come on board.   I’d like to take this opportunity to thank everyone who contributed to this effort – whether it was by giving feedback at the conceptualisation stage, being one of our early adopters, or socialising this concept within your own network – a big thank you for contributing to our journey! 🙏🏼   This is just the beginning and we’re working hard to introduce more interactive features.   In the meantime, check it out and come on board Discovery! https://lnkd.in/gVtD5y_h If you have any feedback about your experience on Discovery, do share. We will improve it step by step together. #VentureBlick #Discovery #oneplatform #healthcareinnovationplatform

99

6 Comments

**🚀 Calling All Investors! Join Us in Revolutionizing Healthcare with HealthConnect 🚀** At HealthConnect, we're on a mission to transform the healthcare experience through innovative technology and seamless connectivity. Our cutting-edge app, HealthConnect, bridges the gap between patients and healthcare providers, offering unparalleled convenience, personalized care, and real-time health monitoring. 🔍 **Why HealthConnect?** - Innovative Solution: HealthConnect addresses the critical need for efficient, accessible, and personalized healthcare services. - Market Opportunity: With the digital health market projected to reach $500 billion by 2025, HealthConnect is poised for rapid growth. - **AI Integration:**   - Personalized Healthcare: Our AI-driven algorithms analyze user data to provide personalized health insights and recommendations.  - Predictive Analytics: Utilizing machine learning to predict potential health issues and provide early interventions.  - Chatbot Support: AI-powered chatbots offer round-the-clock assistance, answering medical queries and providing health advice. - Strong Foundation:  - Development Progress: Our app is in the final stages of development, with a user-friendly interface and robust backend infrastructure.  - Clinical Insights: We have collaborated with healthcare professionals to ensure our app meets the highest standards of medical accuracy and usability.  - Initial Feedback: Positive responses from beta testers highlight the app’s potential to improve patient care and streamline healthcare processes. 📈 **Investment Opportunity** We are currently seeking strategic investors who share our vision and passion for improving healthcare. Your investment will help us: - Expand our user acquisition efforts - Enhance our AI technology platform 👥 **Join Our Journey** If you're interested in being part of the HealthConnect revolution and making a meaningful impact in the healthcare industry, let's connect! Reach out to us at info@healthconnect.llc Together, we can make healthcare better, one connection at a time. 💡 #HealthcareInnovation #DigitalHealth #HealthTech #AI #Investors #StartupFunding #HealthConnect

26

1 Comment

Pleased to share some insights into our latest fund SSV II 🛰 🌌 Following the same strategy as its original SpaceTech-focused venture fund, a top-performing fund for its vintage, SSV II aims to build a portfolio of c.30 companies. The Fund has already made nine investments. The 9 companies currently making up the SSV II portfolio are: 💫 Hubble Network – Internet of Things satellite constellation for connecting directly to billions of Bluetooth-enabled devices Delos Insurance Solutions – Space data-powered wildfire home insurance provider ATMOS Space Cargo – Space cargo return service for life sciences Auriga Space – Novel electromagnetic launch system Array Labs- 3D satellite imagery on a global scale Privateer Space - constellation of small SATs for in-Space Situational Awareness (SSA) Ubotica Technologies - Live Earth Intelligence (Space: AI) Renoster - Deep Transparency for nature-based carbon projects constellr - Space data-powered high-precision smart farming services Find out more👀 https://lnkd.in/eS_9w7c3

22

🌟 'aha' moment! The latest startup success findings sparked a sense of satisfaction. 💯 Not surprising, yet so spot on! 💫 🤝 Indeed, it's not just genius ideas or cutting-edge tech. It's the power of team dynamics. 💰 🔎 Venture capitalists understand it, and recent studies underline this pivotal factor. We’ve embraced it at Manigo and have seen the difference it makes. Crucially, it's about culture fit. One misaligned gear can disrupt the entire mechanism, and we all know the pain it entails. 🚀 Manigo is a cumulative effort of a diverse, incredibly driven, and synergistic team ✨, committed to overcoming hurdles together 💪 . We all share the ambition to reshape the tech in fintech. Read on into what fuels startup success in Ilya Strebulaev post:

9

1 Comment

To Launch a New Service, Customers Must Love Your Existing Products. I sat down with Mikhail Lomtadze, CEO of Kaspi.kz (NASDAQ:KSPI), a $24 billion behemoth traded on the Nasdaq and the leading tech platform in Kazakhstan. Mikhail philosophy is that to launch new products successfully, customers must love your existing ones because if current customers don't love a company's products, they won't adopt or recommend any new products being launched. Customers who dislike existing products will spread negativity and not give new products a chance. Ensuring high quality of current products builds trust and loyalty that carries over to gaining adoption of new services. Links to full Fintech Leaders episode ⤵⤵⤵ Substack: https://bit.ly/3z7UGF6   Spotify: https://spoti.fi/4evnszN Apple: https://apple.co/3VMXjVu Youtube: https://bit.ly/3VPjR8s

68

3 Comments

What’s happening in healthtech? 💊🎉 🧪 Formation Bio, an AI drug development startup backed by Sam Altman raised US$372M ft. collabs with OpenAI & Sanofi 💊 HealthNow, raised >$3.4M to help modernise the delivery of employee benefits via their HealthNow Mastercard 🤖 Andromeda secured $3M to scale its humanoid companion robots 🌟 Remarkable Ventures launched the scaler program to support disability, ageing, and health startups from Seed to Series A 🎉 ANDHealth+ & the MRFF announced the companies that’ll receive a share of $3.75M: **Cape Bionics - Digital scanning tech software allowing clinicians to scan patients to create personalised, medical-grade compression garments **Healthily - Conversational Voice AI to an interoperable clinical outreach and patient education platform **Navier Medical -AI-driven medical imaging software for CT scans to unlock personalised treatment options and earlier detection for CVD **Osara Health - Digital engagement platform for those impacted by cancer **Sydney Neuroimaging Analysis Centre - Brain imaging analysis platform utilising AI to analyse brain structures to monitor and manage neurological diseases **Touchstone Life Care - SaaS platform to create digital advanced care plans to improve end-of-life care 🩺 Harrison.ai, the AI medical imaging & diagnostic tool creators, are prepping for a +$100M Series C 🧬 Health Minister Mark Butler launched Ternarx, a new biotech company targeting hard-to-treat cancers with a protein degrader tech 🚨The ACCC raised concerns about the proposed merger between Chemist Warehouse & Sigma Healthcare 🐟 NeoGenix Biosciences pty ltd Biosciences achieved its first pregnancy through SpermSearch AI 🚀 LaunchVic announced the 20 recipients of the MedTech Market Growth Program, a $50k grant to bring lifesaving products to market 🚭 Aus will be the 1st country to ban vape sales outside of pharmacies, but you won't need a prescription to buy them 🤖 The MRFF awarded 10 grants to Aussie unis to harness AI in healthcare 🧬 EvolutionaryScale came out of stealth, ft US$142M to build AI models that can generate novel proteins for scientific research backed by Amazon & NVIDIA Keen for the links & delicious deets?? 🍩🙌 Take a gander at last week's newsletter in the comments below👇😊 --- PS - if you liked this and are keen to join >7900 legends getting health tech and innovation news dropped weekly direct to your inbox, subscribe to our newsletter, What the Health! 💜 📩 #healthtech  #health  #healthcare  #digitalhealth  #medtech  #biotech

96

7 Comments

Transforming Healthcare with an early stage Biotech Aggregator. - 11 Biotech Assets with a Net Present Value of $230 Million - Innovative Therapies in Pain Management, Anti-Obesity, and Cardiovascular Health - Advanced Medical Devices for Surgical Applications Unique Investment Philosophy: -Specializes in enhancing the value of biotech projects at various clinical trial stages -Focus on early-stage investments with significant growth potential -Strategic partnerships with major pharmaceutical companies #InvestmentOpportunity #BiotechInvesting #HealthcareInnovation #BiotechInvestment #VentureCapital #SeriesARaise #InnovativeTherapies #MedicalDevices #HealthTech #BiotechStartup #ClinicalTrials #EarlyStageInvesting #Pharmaceuticals #BiotechGrowth #LifeSciences #InvestorAlert #TransformingHealthcare #BiotechAggregator #InvestmentPhilosophy #StrategicPartnerships

8

1 Comment

💡💼 Dive into the world of startups and venture capital with these curated GPTs tailored for entrepreneurs and investors! From refining business ideas to crafting pitch decks and analysing startup contracts, these tools offer valuable assistance at every stage of the startup journey. 🚀 For startups, tools like Pitch Deck Analyzer and LogoGPT provide invaluable feedback and creative support, while VC GPT and Venture GPT offer pitch training and AI copilot services for investors. Whether you're a founder seeking guidance or a VC looking for insights, these GPTs are your go-to resources for navigating the dynamic landscape of entrepreneurship and investment. Thanks, Rubén D. for sharing this list. #Startups #VentureCapital #Entrepreneurship 📈🔍

6

1 Comment

Simplify to Build Faster and Better Products. I sat down with Mikhail Lomtadze, CEO of Kaspi.kz (NASDAQ:KSPI), a $24 billion behemoth traded on the Nasdaq and the leading tech platform in Kazakhstan. Product launches at Kaspi are approached with a philosophy of drastic simplification. Instead of overwhelming consumers with a fully-featured product from the start, they identify the single most important and necessary feature and release it first. Additional features are introduced incrementally in the following months, leading to an iterative approach that allows the team to gather and incorporate consumer feedback continuously, ensuring the product evolves based on actual user experience and needs. Links to full Fintech Leaders episode ⤵⤵⤵ Substack: https://bit.ly/3z7UGF6   Spotify: https://spoti.fi/4evnszN Apple: https://apple.co/3VMXjVu Youtube: https://bit.ly/3VPjR8s

133

4 Comments

Pleasure to speak at Latitude59 - an action packed technology event of the world's first digital society, Estonia. Latitude59's stage tracks features industry-leading founders, government representatives, funds, and societal activists dedicated to making a positive impact in the world. 🌍🚀 ▫️ Alar Karis is the President of the Republic of Estonia. Until taking office on 11th October 2021, he was the director of the Estonian National Museum (from 2018). President Karis served as the Auditor-General of the Republic of Estonia from 2013-2018. ▪️ Shilpa Karkeraa is the CEO of Myraa Technologies, HQ’d in Singapore running AI & Blockchain innovations across 7 Countries & 11 Industries. She is committed to Pay it Forward with Usha Renal Care Foundation to accelerate better Healthcare. ▫️ Hiroshi Saijou(He/Him) leads the Special Projects and Strategy team at the Group CTO Office of Panasonic Holdings, a global leader in innovation and technology. With more than 25 years of experience in robotics, software, and mobility, he develops and executes the corporate strategy and business plans to drive growth, transformation, and value creation across the group. ▪️ Kat Zhou is the creator of the project <​Design Ethically>, which started out as a framework for applying ethics to the design process and has now grown into a toolkit of speculative activities that help teams forecast the consequences of their products. ▪️ Michael Bjørnlund is the managing partner for the Rockstart Emerging Technologies fund. Rockstart invests from the pre-seed stage in European startups across three domains: AgriFood, Energy, and Emerging Technologies. Rockstart has invested in more than 300 startups since 2012. ▪️ Mareme Dieng is the lead for Market Strategy, Africa at venture capital firm 500 Global, where she’s responsible for leading the market development and expansion of the firm into Africa and the neighboring regions, with a focus on increasing AUM and ecosystem development in emerging countries. ▫️ Sebastian Wossagk is managing partner with Acton Capital, a leading venture capital growth investor based in Munich/Germany. He holds responsible for a large number of investments in both B2C and B2B start-ups, including Tallinn-based SaaS company Klaus, recently acquired by Zendesk. Sebastian has more than 25 years of experience within venture capital, high-tech and consulting. And many more! Thanks Johanna-Riinu Annuk, Kai Isand, Marie, Hayley N. for all the action and impact! See you all soon. #estonia #singapore #event #impact

85

7 Comments

I am excited to share that Antalpha Ventures has invested in the latest funding round of ChainML, a Web3-enabled AI platform. The round was led by industry-leading fund Hack VC, with participation from IOSG Ventures, HashKey Capital, LongHash Ventures, Foresight Ventures, HTX Ventures, Figment Capital, Inception Capital, Hypersphere Ventures, and Alumni Ventures, among others. ChainML unveiled its agentic base layer, TheoriqAI, a framework for autonomous AI agents to accomplish complex tasks. Theoriq leverages blockchain technology for agent registration, payment, and security. By partnering with resource providers, Theoriq aims to provide intuitive access to Web3 value drivers like DeFi, infrastructure, and memecoins. For more information, including quotes from Ron Bodkin, Founder and CEO of ChainML, please refer to Yogita K.'s The Block article below. #AI #Agents #Blockchain #Web3

18

3 Comments

Advice from today's esteemed panel on accessing #healthcare #investment. "It's never too early to build your network with investors. Socialize your ideas to help sharpen your thesis. You can never underestimate the value of early feedback." Rami Hannoush, Ph.D. "Surround yourself with an advisory board that actually helps. They should be working on your behalf to help you access THEIR networks." Jennifer Friel Goldstein "Build your network early and pressure test your story with advisors." Nate Chang "Get to Silicon Valley early and often, and leverage programs like #ValleyReady that CELS - Canadian Entrepreneurs in Life Science offers because it can be game changing for your business." Cedric Bisson

42

7 Comments